Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19

References

• World Health Organization. (2020). Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
   Google Scholar
• Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206.
   PubMed Web of Science ®Google Scholar
• Guo, YR., Cao, QD., Hong, ZS. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res7, 11 (2020). https://doi.org/10.1186/s40779-020-00240–0
   Google Scholar
• Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567.
   PubMed Web of Science ®Google Scholar
• Bazant MZ, Bush JWM. A guideline to limit indoor airborne transmission of COVID-19. Proceedings of the National Academy of Sciences of the United States of America, 2021;118(17):e2018995118.
   Google Scholar
• Greenhalgh T, Jimenez JL, Prather KA, et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603–1605.
   PubMed Web of Science ®Google Scholar
• Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1–9.
   PubMed Web of Science ®Google Scholar
• Yousefifard M, Zali A, Mohamed Ali K, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emergency Med. 2020; 82: 45.http://journals.sbmu.ac.ir/aaem
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19) 2021; Updated on 16 February 2021. cited 2021 Aug 03. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
   Google Scholar
• National Institutes of Health (NIH). USA. COVID-19 Treatment Guidelines. 2021;. cited 2021 Aug 03. https://www.covid19treatmentguidelines.nih.gov/tables/table-2e/
   Google Scholar
• Shakaib B, Zohra T, Ikram A, et al. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: how far have we come? Virol J. 2021;18(1):1–16.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19): hydroxychloroquine. Dated 30 April, 2021. 2021b; cited 2021 Aug 03. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-hydroxychloroquine
   Google Scholar
• World Health Organization. WHO advises that ivermectin only be used to treat COVID-19 within clinical trials. 31 March 2021.2021c; cited 2021 Aug 03. https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials
   Google Scholar
• Li H, Zhou Y, Zhang M, et al. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. 2020;64(6):1–7.
   Web of Science ®Google Scholar
• Rosa SGV, Santos WC. Clinical trials on drug repositioning for COVID-19 treatment. Rev Panam Salud Pública. 2020;44:1.
   Web of Science ®Google Scholar
• Baglivo M, Baronio M, Natalini G, et al. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? Acta Biomed. 2020;91(1):161–164.
   PubMedGoogle Scholar
• Daverey A, Dutta K. COVID-19: eco-friendly hand hygiene for human and environmental safety. J Environ Chem Eng. 2021;9(2):104754.
   PubMed Web of Science ®Google Scholar
• Jin L, Black W, Sawyer T. Application of environment-friendly rhamnolipids against transmission of enveloped viruses like sars-cov2. Viruses. 2021;13(2):2.
   Web of Science ®Google Scholar
• Smith ML, Gandolfi S, Coshall PM, et al. Biosurfactants: a Covid-19 Perspective. Front Microbiol. 2020;11(June):1–8.
   PubMedGoogle Scholar
• Subramaniam MD, Venkatesan D, Iyer M, et al. Biosurfactants and anti-inflammatory activity: a potential new approach towards COVID-19. Curr Opin Environ Sci Health. 2020;17:72–81.
   PubMedGoogle Scholar
• Ejike Ogbonna K, Victor Agu C, Okonkwo CC, et al. Use of spondias mombin fruit pulp as a substrate for biosurfactant production. Bioengineered. 2021;12(1):1–12.
   PubMed Web of Science ®Google Scholar
• Patel S, Homaei A, Patil S, et al. Microbial biosurfactants for oil spill remediation: pitfalls and potentials. Appl Microbiol Biotechnol. 2019;103(1):27–37.
   PubMed Web of Science ®Google Scholar
• Gudiña EJ, Rangarajan V, Sen R, et al. Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci. 2013;34(12):667–675.
   PubMed Web of Science ®Google Scholar
• Pacwa-Płociniczak M, Płaza GA, Piotrowska-Seget Z, et al. Environmental applications of biosurfactants: recent advances. Int J Mol Sci. 2011;12(1):633–654.
   PubMed Web of Science ®Google Scholar
• Shah V, Daverey A. Effects of sophorolipids augmentation on the plant growth and phytoremediation of heavy metal contaminated soil. J Clean Prod. 2021;280:124406.
   Web of Science ®Google Scholar
• Huang X, Lu Z, Zhao H, et al. Antiviral activity of antimicrobial lipopeptide from Bacillus subtilis fmbj against pseudorabies virus, porcine parvovirus, newcastle disease virus and infectious bursal disease virus in vitro. Int J Pept Res Ther. 2006;12(4):373–377.
   Web of Science ®Google Scholar
• Kang BR, Park JS, Jung WJ. Antiviral activity by lecithin-induced fengycin lipopeptides as a potent key substrate against Cucumber mosaic virus. Microb Pathog. 2021;155(December2020):104910.
   PubMedGoogle Scholar
• Huang C, Hu C, Sun G, et al. Antimicrobial finish of cotton fabrics treated by sophorolipids combined with 1,2,3,4-butanetetracarboxyic acid. Cellulose. 2020;27(5):2859–2872.
   Web of Science ®Google Scholar
• Daverey A, Pakshirajan K. Sophorolipids from Candida bombicola using mixed hydrophilic substrates: production, purification and characterization. Colloids Surf B Biointerfaces. 2010;79(1):246–253.
   PubMed Web of Science ®Google Scholar
• Elshafie AE, Joshi SJ, Al-Wahaibi YM, et al. Sophorolipids production by candida bombicola ATCC 22214 and its potential application in microbial enhanced oil recovery. Front Microbiol. 2015;6(3):743–753.
   PubMedGoogle Scholar
• Haggag Y, Elshikh M, El-Tanani M, et al. Nanoencapsulation of sophorolipids in PEGylated poly(lactide-co-glycolide) as a novel approach to target colon carcinoma in the murine model. Drug Deliv Transl Res. 2020;10(5):1353–1366.
   PubMed Web of Science ®Google Scholar
• Ribeiro IA, Bronze MR, Castro MF, et al. Design of selective production of sophorolipids by Rhodotorula bogoriensis through nutritional requirements. J Mol Recog. 2012;25(11):630–640.
   PubMed Web of Science ®Google Scholar
• Jiménez-Peñalver P, Rodríguez A, Daverey A, et al. Use of wastes for sophorolipids production as a transition to circular economy: state of the art and perspectives. Rev Environ Sci Biotechnol. 2019;18(3):413–435.
   Web of Science ®Google Scholar
• Chen J, Song X, Zhang H, et al. Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells. Appl Microbiol Biotechnol. 2006;72(1):52–59.
   PubMed Web of Science ®Google Scholar
• Gaur VK, Regar RK, Dhiman N, et al. Biosynthesis and characterization of sophorolipid biosurfactant by Candida spp.: application as food emulsifier and antibacterial agent. Bioresour Technol. 2019;285(April):121314.
   PubMedGoogle Scholar
• Haque F, Verma NK, Alfatah M, et al. Sophorolipid exhibits antifungal activity by ROS mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways in: Candida albicans. RSC Adv. 2019;9(71):41639–41648.
   PubMed Web of Science ®Google Scholar
• Mendes RM, Francisco AP, Carvalho FA, et al. Fighting S. aureus catheter-related infections with sophorolipids: electing an antiadhesive strategy or a release one? Colloids Surf B Biointerfaces. 2021;208:112057.
   PubMed Web of Science ®Google Scholar
• Sen S, Borah SN, Kandimalla R, et al. Sophorolipid biosurfactant can control cutaneous dermatophytosis caused by trichophyton mentagrophytes. Front Microbiol. 2020;11(March):1–15.
   PubMedGoogle Scholar
• Silveira VAI, Nishio EK, Freitas CAUQ, et al. Production and antimicrobial activity of sophorolipid against Clostridium perfringens and Campylobacter jejuni and their additive interaction with lactic acid. Biocatal Agric Biotechnol. 2019;21(August):101287.
   Google Scholar
• Tang Y, Ma Q, Du Y, et al. Efficient purification of sophorolipids via chemical modifications coupled with extractions and their potential applications as antibacterial agents. Sep Purif Technol. 2020;245(April):116897.
   Google Scholar
• De Graeve M, De Maeseneire SL, Roelants SL, et al. Starmerella bombicola, an industrially relevant, yet fundamentally underexplored yeast. FEMS Yeast Res. 2018;18(7):foy072.
   Web of Science ®Google Scholar
• Šipiczki M, Ciani M, Csoma H. Taxonomic reclassification of Candida stellata DBVPG 3827. Folia Microbiol. 2005;50:494–498.
   PubMed Web of Science ®Google Scholar
• Azim A, Shah V, Doncel GF, et al. Amino acid conjugated sophorolipids: a new family of biologically active functionalized glycolipids. Bioconjug Chem. 2006;17(6):1523–1529.
   PubMed Web of Science ®Google Scholar
• Gross RA, Shah V. 2007. Anti-herpes virus properties of various forms of sophorolipids. In World patent 2007130738 A1.
   Google Scholar
• Gross RA, Shah V, Doncel GF. 2004. United States Patent Application Publication Pub. No .: US 2004/0121015 A1.
   Google Scholar
• Shah V, Doncel GF, Seyoum T, et al. Sophorolipids, microbial glycolipids with anti-human immunodeficiency virus and sperm-immobilizing activities. Antimicrob Agents Chemother. 2005;49(10):4093–4100.
   PubMed Web of Science ®Google Scholar
• Borsanyiova M, Patil A, Mukherji R, et al. Biological activity of sophorolipids and their possible use as antiviral agents. Folia Microbiol (Praha). 2016;61(1):85–89.
   PubMed Web of Science ®Google Scholar
• Mohamed SK, Asif M, Nazari MV, et al. Antiangiogenic activity of sophorolipids extracted from refined bleached deodorized palm olein. Indian J Pharmacol. 2018;49(5):344–347.
   Google Scholar
• Bluth MH, Kandil E, Mueller CM, et al. Sophorolipids block lethal effects of septic shock in rats in a cecal ligation and puncture model of experimental sepsis. Crit Care Med. 2006;34(1):E188.
   PubMed Web of Science ®Google Scholar
• Strauss JH, Strauss EG. The structure of viruses. Viruses and human disease. Vol. 80. Massachusetts, USA, Elsevier; 2008. p. 35–62.
   Google Scholar
• Conley L, Tao Y, Henry A, et al. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation. Biotechnol Bioeng. 2017;114(4):813–820.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.
   PubMed Web of Science ®Google Scholar
• Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46–e47.
   PubMed Web of Science ®Google Scholar
• Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):e30–e31.
   PubMed Web of Science ®Google Scholar
• Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20(4):400–402.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang X, Ni L, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250(February):117583.
   PubMedGoogle Scholar
• Hagler M, Smith-Norowitz TA, Chice S, et al. Sophorolipids Decrease IgE Production in U266 Cells by Downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6. J Allergy Clin Immunol. 2007;119(1):S263.
   Web of Science ®Google Scholar
• Arabiyat AS, Diaz-Rodriguez P, Erndt-Marino JD, et al. Effect of poly(sophorolipid) functionalization on human mesenchymal stem cell osteogenesis and immunomodulation. ACS Appl Bio Mater. 2019;2(1):118–126.
   PubMedGoogle Scholar
• Wadgaonkar R, Gross RA, Butnariu D, et al. Lung Injury Treatment Pct/US08/62759; 2010. https://patentimages.storage.googleapis.com/7d/2a/15/6473be8dbface8/US20100130442A1.pdf
   Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
   PubMed Web of Science ®Google Scholar
• Fu SL, Wallner SR, Bowne WB, et al. Sophorolipids and their derivatives are lethal against human pancreatic cancer cells. J Surg Res. 2008;148(1):77–82.
   PubMed Web of Science ®Google Scholar
• Shao L, Song X, Ma X, et al. Bioactivities of sophorolipid with different structures against human esophageal cancer cells. J Surg Res. 2012;173(2):286–291.
   PubMed Web of Science ®Google Scholar
• Li H, Guo W, Ma X, et al. In vitro and in vivo anticancer activity of sophorolipids to human cervical cancer. Appl Biochem Biotechnol. 2017;181(4):1372–1387.
   PubMed Web of Science ®Google Scholar
• Nawale L, Dubey P, Chaudhari B, et al. Anti-proliferative effect of novel primary cetyl alcohol derived Sophorolipids against human cervical cancer cells HeLa. PLoS ONE. 2017;12(4):1–14.
   Web of Science ®Google Scholar
• Shen Z., Xiao Y., Kang L., et al. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients with Coronavirus Disease 2019. Clin Infect Dis. 2020;71(15):713–720.
   PubMed Web of Science ®Google Scholar
• Callaghan B, Lydon H, Roelants SLKW, et al. Lactonic sophorolipids increase tumor burden in apcmin± mice. PLOS ONE. 2016;11(6):e0156845.
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Henry BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020;8(7):497.
   PubMed Web of Science ®Google Scholar
• Inès M, Dhouha G. Glycolipid biosurfactants: potential related biomedical and biotechnological applications. Carbohydr Res. 2015;416:59–69.
   PubMed Web of Science ®Google Scholar
• Haferburg D, Hommel R, Kleber H‐P, et al. Antiphytovirale Aktivität von Rhamnolipid aus Pseudomonas aeruginosa. Acta Biotechnologica. 1987;7(4):353–356.
   Google Scholar